Ronald Blue Trust, Inc. Beyond Spring Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.01 Billion
- Q1 2024
Shares
1 transactions
Others Institutions Holding BYSI
# of Institutions
24Shares Held
5.44MCall Options Held
30.3KPut Options Held
1.8K-
Decheng Capital LLC Menlo Park, CA4.96MShares$11.7 Million2.37% of portfolio
-
Black Rock Inc. New York, NY215KShares$507,7840.0% of portfolio
-
Capstone Capital Wealth Advisors Henderson, NV50.5KShares$119,1800.16% of portfolio
-
State Street Corp Boston, MA32.2KShares$75,9920.0% of portfolio
-
Y Intercept (Hong Kong) LTD30.7KShares$72,3970.01% of portfolio
About BeyondSpring Inc.
- Ticker BYSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,928,900
- Market Cap $91.9M
- Description
- BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...